Markets:

Overview

News

Currencies

International

Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

17.17 -0.31 (-1.77%)

Streaming Delayed Price Updated: 3:40 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about EyePoint, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

EyePoint Pharmaceuticals: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments

May 02, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

Via FinancialNewsMedia

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 24, 2023

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday ↗

April 24, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings ↗

April 21, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...

Via Benzinga

EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 4/21

April 21, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 21, 2023

Via Benzinga

Earnings Preview: EyePoint Pharmaceuticals ↗

March 01, 2023

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

Gold Down Over 1%; US Composite PMI Rises In April ↗

April 21, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...

Via Benzinga

US Stocks Mostly Lower; Nasdaq Down 50 Points ↗

April 21, 2023

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...

Via Benzinga

Eyepoint Pharmaceuticals Inc. (NASDAQ: EYPT) Leading the Way in Monday Trading Based on Percentage Gain

March 27, 2023

Via Investor Brand Network

Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout ↗

March 16, 2023

Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.

Via Benzinga

EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024 ↗

March 02, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported Q4 revenues of $10.5 million, down 8.8% Y/Y, almost in line with the consensus of $10.40 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 12, 2023

Via Benzinga

EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm

December 28, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm

December 23, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm

December 16, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating GrafTech, BRP, Cantaloupe, and EyePoint and Encourages Investors to Contact the Firm

December 12, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating GrafTech, BRP, Cantaloupe, and EyePoint and Encourages Investors to Contact the Firm

December 02, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Establishment and Encourages Investors to Contact the Firm

November 21, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials ↗

November 14, 2022

Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Intuit and Encourages Investors to Contact the Firm

November 11, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Cantaloupe, EyePoint, Spectrum, and F45 Training and Encourages Investors to Contact the Firm

November 06, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

NASDAQ:EYPT Investor Alert: Investigation over Potential Securities Laws Violations by EyePoint Pharmaceuticals, Inc. ↗

November 02, 2022

San Diego, CA -- (SBWIRE) -- 11/02/2022 -- EyePoint Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

EyePoint Pharmaceuticals: Q3 Earnings Insights ↗

November 02, 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Vintage Wine, Flowserve, Cantaloupe, and EyePoint and Encourages Investors to Contact the Firm

October 31, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.